3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
3
Brain Neoplasms
3
Radiation Pneumonitis
1
Radiation Injuries
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Optic Neuritis
1
Neoplasms, Fibrous Tissue
1
Neoplasms, Connective and Soft Tissue
1
Neoplasms, Connective Tissue
1
Neoplasms by Histologic Type
1
Neoplasm Metastasis
1
Myelitis, Transverse
1
Myelitis
1
Myasthenia Gravis
1
Musculoskeletal Diseases
1
Lung Neoplasms
1
Lung Diseases, Interstitial
1
Joint Diseases
1
Glioma
1
Fibroma
1
Dupuytren Contracture
1
Contracture
1
Connective Tissue Diseases
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
N-(4-((5-(hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo(1,2-a)pyrimidine-6-carboxamide
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Myelitis, Transverse
×
Adrenal Cortex Hormones
×
Clear all
NCT07100990
2026-05-05
TIMELY-PLEX
Mayo Clinic
Phase 3
Recruiting
382 enrolled